You can:
Name | Cholecystokinin receptor type A |
---|---|
Species | Homo sapiens (Human) |
Gene | CCKAR |
Synonym | cholecystokinin-1 receptor CCK1-R CCK1 receptor CCK-AR CCK-A receptor [ Show all ] |
Disease | Pancreatic cancer; Obesity Eating disorder Pancreatic disease Gallstone prophylaxis; Obesity Gastrointestinal disease [ Show all ] |
Length | 428 |
Amino acid sequence | MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPNLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTANMCRFLLPNDVMQQSWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFEASQKKSAKERKPSTTSSGKYEDSDGCYLQKTRPPRKLELRQLSTGSSSRANRIRSNSSAANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTASAERRLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGPPGARGEVGEEEEGGTTGASLSRFSYSHMSASVPPQ |
UniProt | P32238 |
Protein Data Bank | 1d6g |
GPCR-HGmod model | P32238 |
3D structure model | This structure is from PDB ID 1d6g. |
BioLiP | BL0007611 |
Therapeutic Target Database | T28330 |
ChEMBL | CHEMBL1901 |
IUPHAR | 76 |
DrugBank | BE0000402 |
Name | NSC157267 |
---|---|
Molecular formula | C13H16ClNO2 |
IUPAC name | (E)-3-(4-chlorophenyl)-N-(1-hydroxybutan-2-yl)prop-2-enamide |
Molecular weight | 253.726 |
Hydrogen bond acceptor | 2 |
Hydrogen bond donor | 2 |
XlogP | 2.3 |
Synonyms | NSC-157267 (E)-3-(4-chlorophenyl)-N-(1-hydroxybutan-2-yl)prop-2-enamide AC1O3OFM CHEMBL3884786 AKOS005832485 |
Inchi Key | PRRQIMZFWXXIRY-VMPITWQZSA-N |
Inchi ID | InChI=1S/C13H16ClNO2/c1-2-12(9-16)15-13(17)8-5-10-3-6-11(14)7-4-10/h3-8,12,16H,2,9H2,1H3,(H,15,17)/b8-5+ |
PubChem CID | 6310476 |
ChEMBL | CHEMBL3884786 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Inhibition | 11.0 % | PMID27876250 | ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218